NPCE Q2 2021 Earnings — NeuroPace, Inc. Revenue & Financial Results | Market Cap Arena

NPCENeuroPace, Inc.

$483M

Q2 2021 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$13M+65.3% YoY

Gross Profit

$9M74.1% margin

Operating Income

-$5M-36.5% margin

Net Income

-$8M-67.3% margin

EPS (Diluted)

$-0.48

QoQ Revenue Growth

+12.6%

Cash Flow

Operating Cash Flow

-$6M

Free Cash Flow

-$6M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$147M

Total Liabilities

$58M

Stockholders' Equity

$89M

Cash & Equivalents

$31M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$13M	$8M	+65.3%
Gross Profit	$9M	$5M	+72.6%
Operating Income	-$5M	-$3M	-33.6%
Net Income	-$8M	-$9M	+3.4%